Name: | Cilastatin |
---|---|
PubChem Compound ID: | 104867 |
Description: | A renal dehydropeptidase-I and leukotriene D4 dipeptidase inhibitor. Since the antibiotic, IMIPENEM, is hydrolyzed by dehydropeptidase-I, which resides in the brush border of the renal tubule, cilastatin is administered with imipenem to increase its effectiveness. The drug also inhibits the metabolism of leukotriene D4 to leukotriene E4. |
Molecular formula: | C16H26N2O5S |
Molecular weight: | 358.454 g/mol |
Name: | Cilastatin |
---|---|
Name (isomeric): | DB01597 |
Drug Type: | small molecule |
Description: | A renal dehydropeptidase-I and leukotriene D4 dipeptidase inhibitor. Since the antibiotic, IMIPENEM, is hydrolyzed by dehydropeptidase-I, which resides in the brush border of the renal tubule, cilastatin is administered with imipenem to increase its effectiveness. The drug also inhibits the metabolism of leukotriene D4 to leukotriene E4. |
Brand name mixture: | Primaxin IV 500(Cilastatin Sodium + Imipenem), Primaxin 500(Cilastatin Sodium + Imipenem), Primaxin 250(Cilastatin Sodium + Imipenem) |
Category: | Protease Inhibitors |
CAS number: | 82009-34-5 |
Indication: | Combined intravenously with imipenem in order to protect it from dehydropeptidase and prolong its antibacterial effect. |
---|---|
Pharmacology: |
Cilastatin is a chemical compound which inhibits the human enzyme dehydropeptidase. Dehydropeptidase is found in the kidney and is responsible for degrading the antibiotic imipenem. Cilastatin is therefore combined intravenously with imipenem in order to protect it from dehydropeptidase and prolong its antibacterial effect. However, cilastatin in a...
show more » |
Mechanism of Action: |
Cilastatin is a specific and reversible renal dehydropeptidase-I inhibitor. Since the antibiotic, imipenem, is hydrolyzed by dehydropeptidase-I, which resides in the brush border of the renal tubule, cilastatin is administered with imipenem to block the metabolism and thus the inactivation of imipenem so that antibacterial levels of imipenem can be...
show more » |
Affected organisms: | Humans and other mammals |
Drug interaction: |
|
---|